Immunological Markers, Prognostic Factors and Challenges Following Curative Treatments for Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related mortalities worldwide. Patients with early-stage HCC are eligible for curative treatments, such as surgical resection, liver transplantation (LT) and percutaneous ablation. Although curative treatments provide excellent lo...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Soon Kyu, Lee, Sung Won, Jang, Jeong Won, Bae, Si Hyun, Choi, Jong Young, Yoon, Seung Kew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508906/
https://www.ncbi.nlm.nih.gov/pubmed/34638613
http://dx.doi.org/10.3390/ijms221910271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508906/
https://www.ncbi.nlm.nih.gov/pubmed/34638613
http://dx.doi.org/10.3390/ijms221910271

Ejemplares similares